A detailed history of Capital Investment Counsel, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 4,081 shares of MRK stock, worth $420,832. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,081
Previous 4,081 -0.0%
Holding current value
$420,832
Previous $505,000 8.32%
% of portfolio
0.07%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$108.61 - $118.38 $15,205 - $16,573
-140 Reduced 3.32%
4,081 $470,000
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $369,084 - $473,216
4,221 New
4,221 $468,000
Q4 2021

Feb 02, 2022

SELL
$72.28 - $90.54 $68,015 - $85,198
-941 Reduced 18.74%
4,081 $313,000
Q2 2021

Jul 27, 2021

BUY
$70.31 - $77.77 $6,679 - $7,388
95 Added 1.93%
5,022 $391,000
Q1 2021

May 05, 2021

BUY
$68.86 - $81.11 $339,273 - $399,628
4,927 New
4,927 $380,000
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $360,428 - $400,002
-5,022 Closed
0 $0
Q3 2020

Oct 19, 2020

BUY
$73.18 - $82.95 $367,509 - $416,574
5,022 New
5,022 $417,000
Q2 2020

Aug 04, 2020

SELL
$70.42 - $80.13 $353,649 - $402,412
-5,022 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $506 - $702
8 Added 0.16%
5,022 $386,000
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $25,834 - $29,150
333 Added 7.11%
5,014 $456,000
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $7,608 - $8,293
-100 Reduced 2.09%
4,681 $394,000
Q4 2018

Feb 05, 2019

BUY
$65.24 - $75.71 $13,047 - $15,141
200 Added 4.37%
4,781 $365,000
Q3 2018

Oct 31, 2018

SELL
$57.69 - $67.84 $14,018 - $16,485
-243 Reduced 5.04%
4,581 $325,000
Q1 2018

May 04, 2018

BUY
$50.96 - $59.23 $32,512 - $37,788
638 Added 15.24%
4,824 $263,000
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $245,592 - $264,262
4,186
4,186 $268,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Investment Counsel, Inc Portfolio

Follow Capital Investment Counsel, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.